300006 莱美药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.859-7.419-4.439-0.425-3.210
总资产报酬率 ROA (%)-0.579-4.961-3.056-0.300-2.297
投入资产回报率 ROIC (%)-0.692-5.902-3.623-0.360-2.799

边际利润分析
销售毛利率 (%)55.01055.76864.38869.33073.498
营业利润率 (%)-9.357-18.844-13.3016.278-10.857
息税前利润/营业总收入 (%)-9.972-20.209-11.865-2.123-7.963
净利润/营业总收入 (%)-7.454-16.312-10.066-1.119-8.624

收益指标分析
经营活动净收益/利润总额(%)42.11852.885115.869-2,145.438151.840
价值变动净收益/利润总额(%)74.20814.40224.9912,421.015-7.682
营业外收支净额/利润总额(%)0.3370.438-40.090-1,464.312-27.631

偿债能力分析
流动比率 (X)2.0112.0882.2082.9282.489
速动比率 (X)1.8171.8671.9572.6242.201
资产负债率 (%)32.64631.48534.05226.59128.483
带息债务/全部投入资本 (%)18.84717.61620.73611.57914.840
股东权益/带息债务 (%)424.550461.123376.362735.392568.487
股东权益/负债合计 (%)204.124216.603192.839270.667244.128
利息保障倍数 (X)17.11215.7565.0050.841-14.654

营运能力分析
应收账款周转天数 (天)114.274116.208134.811131.612153.285
存货周转天数 (天)171.693190.452236.777244.692276.541